How Does iTind Work?
Mechanism of Action
iTind
iTind is a temporarily implanted nitinol device. The minimally invasive treatment with iTind aims to deliver rapid and effective relief from BPH symptoms.
iTind is inserted in an efficient and straightforward procedure with a short learning curve. Through gentle pressure on the tissue and localized ischemia, the iTind aims to reshape the tissue of the prostatic urethra and the bladder neck, creating new channels through which urine can flow.
Patients are able to return home during the 5-7 day treatment. After the implantation period of 5-7 days, the device is completely removed.
How Does iTind Work?
The iTind is placed into the prostatic urethra in a narrow, folded configuration.
During the implantation period of 5-7 days, the device expands and exerts gentle pressure at three precise points to remodel the prostatic urethra and the opening to the bladder.
After 5-7 days the device is completely removed, leaving a wider opening through which urine can flow, and relieving the symptoms of BPH for years to come.
Clinical Evidence
Scientific Publications 1
Clinical data demonstrate that the first generation TIND boasts a durability of three years, and powerful efficacy at 36 months is also demonstrated by the second-generation and commercially available iTind.
- Rapid and effective relief from BPH symptoms. 2 , 3 , 4 , 5
- Lower risk profile than more invasive procedures. 2 , 3 , 4 , 5
- Routinely catheter free procedure. 2 , 3 , 4 , 5
- Preserves sexual and ejaculatory function. 2 , 3 , 4 , 5
- No permanent implant resulting from the procedure. 2 , 3 , 4 , 5
- Straightforward procedure.
➝ Please click on the image to get a detailed view
Downloads
References
- 1.Company sponsored trials under the responsibility of Medi-Tate.
- 2.3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction
- 3.3-Year results following treatment with the second generation of the temporary implantable nitinoldevice in men with LUTS secondary to benign prostatic obstruction
- 4.The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial.
- 5.Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study.